Search alternatives:
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
ht decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), e non (Expand Search)
5 ht » 5 h (Expand Search)
Showing 21 - 40 results of 146,891 for search '(( 5 non decrease ) OR ((( 10 ((mg decrease) OR (a decrease)) ) OR ( 5 ht decrease ))))', query time: 1.03s Refine Results
  1. 21
    Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints.

    Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints. by Aeron M. Small (9617751)

    Published 2020
    “…<p>Odds ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
    Save to List
    Saved in:
  2. 22
    Impaired Ubr5 function results in increased canonical and decreased non-canonical HH signalling.

    Impaired Ubr5 function results in increased canonical and decreased non-canonical HH signalling. by David Mellis (2833469)

    Published 2021
    Save to List
    Saved in:
  3. 23
    Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on pre-specified atherosclerotic traits.

    Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on pre-specified atherosclerotic traits. by Aeron M. Small (9617751)

    Published 2020
    “…<p>Odds Ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on primary atherosclerotic traits for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
    Save to List
    Saved in:
  4. 24
    Methyl Gallate (MG) treatment decreases hepatocellular carcinoma (HCC) cell survival.

    Methyl Gallate (MG) treatment decreases hepatocellular carcinoma (HCC) cell survival. by Chien-Yu Huang (802982)

    Published 2021
    Save to List
    Saved in:
  5. 25
    5-HT supplementation inhibits mitophagy.

    5-HT supplementation inhibits mitophagy. by Li Gao (131516)

    Published 2024
    Save to List
    Saved in:
  6. 26
    Additional file 5 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 5 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  7. 27
    Effect of 5-HT depletion via pCPA on incentive.

    Effect of 5-HT depletion via pCPA on incentive. by Yukiko Hori (299784)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 28
    Metformin lotion decreases collagen III levels in the wounded skin of rats after 10 days of wound healing.

    Metformin lotion decreases collagen III levels in the wounded skin of rats after 10 days of wound healing. by Jianying Zhang (256508)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 29
    Metformin lotion decreases collagen III levels in the wounded skin of rats after 10 days of wound healing.

    Metformin lotion decreases collagen III levels in the wounded skin of rats after 10 days of wound healing. by Jianying Zhang (256508)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 30
    Occupancy estimation.

    Occupancy estimation. by Yukiko Hori (299784)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 31
    MVK activates microglia and decreases phagocytosis.

    MVK activates microglia and decreases phagocytosis. by Ren Y. Sato (16914027)

    Published 2023
    Save to List
    Saved in:
  12. 32
    ROS and superoxide decrease in the dormant form of mycobacteria.

    ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

    Published 2019
    Save to List
    Saved in:
  13. 33
    Genetic interaction of OPRM1 and 5-HT1a.

    Genetic interaction of OPRM1 and 5-HT1a. by Jeanette Tour (10790855)

    Published 2022
    Save to List
    Saved in:
  14. 34
    Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment.

    Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

    Published 2022
    Save to List
    Saved in:
  15. 35
    Non-Steady-State Fickian Diffusion Models Decrease the Estimated Gel Layer Diffusion Coefficient Uncertainty for Diffusive Gradients in Thin-Films Passive Samplers

    Non-Steady-State Fickian Diffusion Models Decrease the Estimated Gel Layer Diffusion Coefficient Uncertainty for Diffusive Gradients in Thin-Films Passive Samplers by Samuel D. Hodges (16412358)

    Published 2023
    “…A finite difference model (FDM) developed based on Fick’s second law with non-steady-state (N-SS) flux decreased uncertainty in <i>D</i><sub>Gel</sub> tenfold. …”
    Save to List
    Saved in:
  16. 36
    Individual dynamics of blood parameters.

    Individual dynamics of blood parameters. by Ekaterina A. Bryushkova (13360122)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 37
    Image3_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.TIF

    Image3_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.TIF by Sandra Torres (3361256)

    Published 2021
    Save to List
    Saved in:
  18. 38
    Image2_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.JPEG

    Image2_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.JPEG by Sandra Torres (3361256)

    Published 2021
    Save to List
    Saved in:
  19. 39
    Image4_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.TIF

    Image4_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.TIF by Sandra Torres (3361256)

    Published 2021
    Save to List
    Saved in:
  20. 40
    Image1_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.TIF

    Image1_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.TIF by Sandra Torres (3361256)

    Published 2021
    Save to List
    Saved in:

Search Tools: